Designing Immune Solutions Through Engineering
At the UChicago Pritzker School of Molecular Engineering (UChicago PME), students and researchers apply engineering principles to the immune system, developing materials, devices, and computational approaches that advance the prevention, diagnosis, and treatment of disease. Working alongside leading faculty and with access to national-lab resources, they turn fundamental immune science into practical medical solutions.
Immunoengineering and Bioengineering News
-
George Shultz Innovation Fund awards $250K to UChicago PME-founded startup Signl
June 18, 2026The George Shultz Innovation Fund has selected two University of Chicago startups, Parasol Medtech and Signl, for an investment of $250,000 each. This year’s finals marked 15 years of the George... -
Four UChicago PME faculty members receive Biohub grants
May 19, 2026Biological research has always had one unavoidable flaw. Dynamic, living processes that move and change over time need to be studied in snapshots. It has always been the nature of studying living... -
Biohub grant to boost early detection for Alzheimer’s, Parkinson’s
May 13, 2026One of the most heartbreaking aspects of neurodegenerative diseases like Alzheimer’s and Parkinson’s is that by the time a disease is diagnosed, it’s often too late for effective treatment. “With...
Faculty Advancing Immune Innovation
UChicago PME faculty bring together expertise in materials science, immunology, data science, and molecular engineering to design technologies that can activate, suppress, or guide immune responses. Their work spans basic discovery through translational applications, with the goal of improving human health at scale.
Engineering the Immune System for Real-World Impact
Collaborations Advancing Human Health
Through partnerships with national laboratories, clinical researchers, and industry leaders, UChicago PME connects immunoengineering innovation to real-world deployment, bridging discovery and patient impact.
Spotlights
-
-
Joey Federico
Riesenfeld GroupJoey Federico turns real-world clinical insights into scientific discoveries that could lead to new therapies. -
Michelle Bessiake
Esser-Kahn Group/ Zemmour LabMichelle Bessiake focuses on understanding regulatory T cells and the diseases that manifest when they aren’t functional. -
Jeremiah Kim
Esser-Kahn LabJeremiah Kim works on increasing the effectiveness of commercially available vaccines and minimizing the complications associated with them.
Prepare to engineer the future of human health through immunoengineering, transforming immune science into real-world solutions.
Immunoengineering Events
UChicago PME is organized into interdisciplinary groups, including the Institute for Materials and Sustainability, Immunoengineering and Bioengineering Institute, and the Chicago Quantum Institute, as well as cross-cutting Centers.